Abstract

Large-conductance Ca2+-activated potassium (BKCa) channels are key determinants of vascular smooth muscle excitability. Impaired BKCa channel function through remodeling of BKCa β1 expression and function contributes to vascular complications in animal models of diabetes. Yet, whether similar alterations occur in native vascular smooth muscle from humans with type 2 diabetes is unclear. In this study, we evaluated BKCa function in vascular smooth muscle from small resistance adipose arteries of non-diabetic and clinically diagnosed type 2 diabetic patients. We found that BKCa channel activity opposes pressure-induced constriction in human small resistance adipose arteries, and this is compromised in arteries from diabetic patients. Consistent with impairment of BKCa channel function, the amplitude and frequency of spontaneous BKCa currents, but not Ca2+ sparks were lower in cells from diabetic patients. BKCa channels in diabetic cells exhibited reduced Ca2+ sensitivity, single-channel open probability and tamoxifen sensitivity. These effects were associated with decreased functional coupling between BKCa α and β1 subunits, but no change in total protein abundance. Overall, results suggest impairment in BKCa channel function in vascular smooth muscle from diabetic patients through unique mechanisms, which may contribute to vascular complications in humans with type 2 diabetes.

Highlights

  • The World Health Organization estimates that ~350 million people worldwide have non-insulin-dependent type 2 diabetes, a number that is expected to double by 20301

  • To establish whether BKCa channel function is impaired in native vascular smooth muscle cells during type 2 diabetes, small diameter arteries were dissected from adipose tissue obtained from obese non-diabetic and clinically diagnosed type 2 diabetic patients undergoing surgical sleeve gastrectomy

  • In this study we report three major novel findings related to BKCa channels in native small diameter adipose arteries and vascular smooth muscle cells from non-diabetic and type 2 diabetic patients

Read more

Summary

Introduction

The World Health Organization estimates that ~350 million people worldwide have non-insulin-dependent type 2 diabetes, a number that is expected to double by 20301. Large-conductance Ca2+-activated potassium (BKCa) channels play a key role in control of vascular smooth muscle contractility via tonic regulation of membrane potential[13]. We investigated BKCa channel function in freshly isolated, small resistance adipose arteries and corresponding native vascular smooth muscle cells from obese non-diabetic and clinically diagnosed type 2 diabetic patients. Data revealed a reduction in iberiotoxin (IbTx) sensitivity of intact arteries from diabetic patients This was associated with impaired BKCa channel activity due to decreased BKCa β1 function in diabetic vascular smooth muscle cells. Results suggest a mechanism for altered vascular BKCa channel function in patients with type 2 diabetes with similar, but not identical features to those observed in animal models of diabetes

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call